FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称VISILIZUMAB
异名/同义词HUM291
HUM-291
IMMUNOGLOBULIN G2 (HUMAN-MOUSE MONOCLONAL HUM291 .GAMMA.2-CHAIN ANTI-HUMAN ANTIGEN CD3), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUM291 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G2 (HUMAN-MOUSE MONOCLONAL HUM291 .GAMMA.2-CHAIN ANTI-HUMAN ANTIGEN CD3), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HUM291 .KAPPA.-CHAIN, DIMER
MAB HUMANIZED (IGG2) ANTI P09693 (CD3G_HUMAN) (HUM291)
MAB HUMANIZED TO CD3+ T CELLS
NUVION
VISILIZUMAB
VISILIZUMAB [INN]
VISILIZUMAB [USAN]
VISILIZUMAB [WHO-DD]
CAS登记号219716-33-3
物质唯一标识(Unique Ingredient Identifier)H18SKU3289
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System